These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 38314877

  • 1. Changes in branched-chain amino acids in an infant with maple syrup urine disease during perioperative pediatric liver transplant: A case report.
    Saeyup P, Tubjaroen C, Kamolvisit W, Chongsrisawat V, Thaveepunsan W.
    Paediatr Anaesth; 2024 Apr; 34(4):366-370. PubMed ID: 38314877
    [Abstract] [Full Text] [Related]

  • 2. Metabolic Control and "Ideal" Outcomes in Liver Transplantation for Maple Syrup Urine Disease.
    Ewing CB, Soltys KA, Strauss KA, Sindhi R, Vockley J, McKiernan P, Squires RH, Bond G, Ganoza A, Khanna A, Mazariegos GV, Squires JE.
    J Pediatr; 2021 Oct; 237():59-64.e1. PubMed ID: 34153280
    [Abstract] [Full Text] [Related]

  • 3. Living donor liver transplantation in maple syrup urine disease - Case series and world's youngest domino liver donor and recipient.
    Mohan N, Karkra S, Rastogi A, Vohra V, Soin AS.
    Pediatr Transplant; 2016 May; 20(3):395-400. PubMed ID: 26869348
    [Abstract] [Full Text] [Related]

  • 4. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA, Carson VJ, Soltys K, Young ME, Bowser LE, Puffenberger EG, Brigatti KW, Williams KB, Robinson DL, Hendrickson C, Beiler K, Taylor CM, Haas-Givler B, Chopko S, Hailey J, Muelly ER, Shellmer DA, Radcliff Z, Rodrigues A, Loeven K, Heaps AD, Mazariegos GV, Morton DH.
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [Abstract] [Full Text] [Related]

  • 5. Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease.
    Kadohisa M, Matsumoto S, Sawada H, Honda M, Murokawa T, Hayashida S, Ohya Y, Lee KJ, Yamamoto H, Mitsubuchi H, Endo F, Inomata Y.
    Pediatr Transplant; 2015 May; 19(3):E66-9. PubMed ID: 25708273
    [Abstract] [Full Text] [Related]

  • 6. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F, Schwartz IV, Benkert AR, Seda Neto J, Miura I, Chapchap P, da Fonseca EA, Vieira S, Zanotelli ML, Pinto e Vairo F, Camelo JS, Margutti AV, Mazariegos GV, Puffenberger EG, Strauss KA.
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [Abstract] [Full Text] [Related]

  • 7. Successful domino liver transplantation in maple syrup urine disease using a related living donor.
    Feier FH, Miura IK, Fonseca EA, Porta G, Pugliese R, Porta A, Schwartz IV, Margutti AV, Camelo JS, Yamaguchi SN, Taveira AT, Candido H, Benavides M, Danesi V, Guimaraes T, Kondo M, Chapchap P, Neto JS.
    Braz J Med Biol Res; 2014 Jun; 47(6):522-6. PubMed ID: 24770567
    [Abstract] [Full Text] [Related]

  • 8. Outcomes from a Single Transplant Center of 5 Pediatric Cases of Domino Liver Transplantation from Live Donors with Maple Syrup Urine Disease.
    Zhang JP, Zhu ZJ, Sun LY, Wei L, Qu W, Zeng ZG, Zhang HM, Liu Y.
    Ann Transplant; 2023 May 30; 28():e939893. PubMed ID: 37248682
    [Abstract] [Full Text] [Related]

  • 9. Heterozygous liver transplantation for maple syrup urine disease: First European reported case.
    Roilides I, Xinias I, Mavroudi A, Ioannou H, Savopoulou P, Imvrios G.
    Pediatr Transplant; 2016 Sep 30; 20(6):846-50. PubMed ID: 27357264
    [Abstract] [Full Text] [Related]

  • 10. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M, Guerreiro G, Girardi J, Ribas G, Vargas CR.
    Int J Dev Neurosci; 2023 Oct 30; 83(6):489-504. PubMed ID: 37340513
    [Abstract] [Full Text] [Related]

  • 11. Technique and outcome of domino liver transplantation from patients with maple syrup urine disease: Expanding the donor pool for live donor liver transplantation.
    Celik N, Kelly B, Soltys K, Squires JE, Vockley J, Shellmer DA, Strauss K, McKiernan P, Ganoza A, Sindhi R, Bond G, Mazariegos G, Khanna A.
    Clin Transplant; 2019 Nov 30; 33(11):e13721. PubMed ID: 31556146
    [Abstract] [Full Text] [Related]

  • 12. Domino hepatic transplantation in maple syrup urine disease.
    Barshop BA, Khanna A.
    N Engl J Med; 2005 Dec 01; 353(22):2410-1. PubMed ID: 16319396
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of the acute crisis in maple syrup urine disease.
    Nyhan WL, Rice-Kelts M, Klein J, Barshop BA.
    Arch Pediatr Adolesc Med; 1998 Jun 01; 152(6):593-8. PubMed ID: 9641714
    [Abstract] [Full Text] [Related]

  • 14. Domino liver transplantation in maple syrup urine disease.
    Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA.
    Liver Transpl; 2006 May 01; 12(5):876-82. PubMed ID: 16628687
    [Abstract] [Full Text] [Related]

  • 15. A case of classical maple syrup urine disease that was successfully managed by living donor liver transplantation.
    Takano C, Ishige M, Ogawa E, Usui H, Kagawa R, Tajima G, Fujiki R, Fukao T, Mizuta K, Fuchigami T, Takahashi S.
    Pediatr Transplant; 2017 Aug 01; 21(5):. PubMed ID: 28612395
    [Abstract] [Full Text] [Related]

  • 16. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
    Felber SR, Sperl W, Chemelli A, Murr C, Wendel U.
    Ann Neurol; 1993 Apr 01; 33(4):396-401. PubMed ID: 8489211
    [Abstract] [Full Text] [Related]

  • 17. Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease.
    Heindel W, Kugel H, Wendel U, Roth B, Benz-Bohm G.
    Pediatr Radiol; 1995 Apr 01; 25(4):296-9. PubMed ID: 7567243
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation in maple syrup urine disease.
    Wendel U, Saudubray JM, Bodner A, Schadewaldt P.
    Eur J Pediatr; 1999 Dec 01; 158 Suppl 2():S60-4. PubMed ID: 10603101
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Amino Acid Homeostasis, Neurodevelopmental and Growth Profiles Following Liver Transplantation in Maple Syrup Urine Disease.
    Vasudevan AK, Shanmugam N, Rammohan A, Balakrishnan U, Menon J, Iqbal MAUH, Mohammed GMO, Kaliamoorthy I, Rela M.
    Pediatr Transplant; 2024 Sep 01; 28(6):e14845. PubMed ID: 39158064
    [Abstract] [Full Text] [Related]

  • 20. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J, Jakher Y, Ahrens-Nicklas RC.
    Int J Mol Sci; 2020 Oct 11; 21(20):. PubMed ID: 33050626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.